Expectorants
Expectorants - Related Videos
01:23
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
0 Views •
2024
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief. Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
09:17
Psychophysical Tracking Method to Measure Taste Preferences in Children and Adults
0 Views •
Cited by 10 •
2016
Sweet taste has powerful hedonic appeal among people of all ages, particularly children. Described herein is a reliable and valid method that can be used to determine the level of sweetness most preferred, making it a valuable psychophysical tool for scientists.
08:10
Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
0 Views •
Cited by 48 •
2012
The Xpert MTB/RIF test integrates sample decontamination, hands-free operation, on-board sample processing, and ultra-sensitive hemi-nested PCR for the simultaneous detection of Mycobacterium tuberculosis and rifampicin resistance, either in expectorated sputum or concentrated sputum sediments, in approximately two hours. Testing is standardized and requires only moderate laboratory infrastructure and training.
FAQs
Their effects make respiratory secretions easier to move by increasing airway fluid or reducing mucus viscosity. This allows cilia, the small structures that transport material along airway surfaces, to move secretions more effectively. Coughing then assists removal rather than being directly blocked. The practical result is improved transport of mucus when secretions are contributing to congestion.
Hydration supports the airway-fluid conditions needed for mucus transport. When secretions are less difficult to move, ciliary activity and coughing can work together more effectively to clear them. Therefore, the response to an expectorant may depend partly on maintaining adequate hydration, while the medication itself does not remove the underlying respiratory illness causing mucus production.
Expectorants support the clearance of mucus, whereas cough-suppressing medicines act to reduce the cough reflex. This distinction matters because a productive cough helps transport respiratory secretions out of the airways. Selecting between these approaches depends on the type of cough and the therapeutic goal: facilitating secretion removal differs from directly limiting coughing.
Guaifenesin is a commonly used example of an expectorant and illustrates the pharmacologic goal of facilitating mucus clearance rather than directly suppressing cough. Its relevance is greatest when airway secretions contribute to congestion and need to be transported. The expected clinical benefit still depends on the underlying illness and on conditions that support effective mucus movement.
An expectorant may be considered when a patient has a productive cough with congestion involving respiratory secretions. The purpose is to support clearance, not simply to eliminate coughing. Clinical selection should account for the underlying respiratory condition, because improving mucus transport may be useful in one setting but may not address the principal cause of symptoms.
Meaningful relief depends on more than the medication alone. The underlying illness, the amount and viscosity of respiratory mucus, hydration, and the patient’s ability to cough and move secretions all influence the outcome. In pharmacotherapy, these factors help explain why expectorants may support congestion relief for some productive coughs without providing the same benefit in every respiratory condition.